Global Oncology Drug Market Size, Share, Analysis, Trends, Growth, Forecasts 2032
Oncology Drug Market Analysis by Therapeutic Models (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), by Cancer Type (Breast Cancer, Blood Cancer, Prostate Cancer, Skin Cancer, Lung Cancer, Others), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 146.9 Billion | USD 473.1 Billion | 14.0% | 2023 |
Table Of Content
- Chapter 1 Preface
- 1.1 Report Description
- 1.1 Report Scope
- Chapter 2 Research Methodology
- 2.1 Research Methodology
- 2.2 Secondary Research
- 2.3 Primary Research
- 2.4 Models
- 2.4.1 Company Share Analysis Model
- 2.4.2 Revenue Based Modelling
- 2.5 Research Limitations
- Chapter 3 Executive Summary
- 3.1 Global Onculogy Drug Market, 2016 – 2026 (USD Million)
- 3.2 Global Onculogy Drug Market: Snapshot
- Chapter 4 Onculogy Drug Market – Industry Analysis
- 4.1 Introduction
- 4.2 Market Drivers
- 4.2.1 Driving Factor 1 Analysis
- 4.2.2 Driving Factor 2 Analysis:
- 4.3 Market Restraints
- 4.3.1 Restraining Factor Analysis
- 4.4 Market Opportunities
- 4.4.1 Market Opportunity & Use-case Analysis
- 4.4.2 Use – Cases for Onculogy Drug
- 4.5 Porter’s Five Forces Analysis
- 4.6 COVID 19 Impact Analysis
- 4.6.1.1 Impact on Product Development and Technology Adoption
- 4.6.1.2 Gap Analysis
- Chapter 5 Investment Proposition Analysis
- 5.1 Global Onculogy Drug Market Attractiveness, By Therapeutic Models
- 5.2 Global Onculogy Drug Market Attractiveness, By Cancer Type
- 5.3 Global Onculogy Drug Market Attractiveness, By Region
- Chapter 6 Competitive Landscape
- 6.1 Company Market Share Analysis - 2019
- 6.1.1 Global Onculogy Drug Market: Company Market Share, 2019
- 6.2 Strategic Developments
- 7.1 Global Onculogy Drug Market Overview: By Therapeutic Models
- 7.1.1 Global Onculogy Drug Market Revenue Share, By Therapeutic Models, 2019 & 2026
- 7.2 Global Onculogy Drug Market Analysis/Overview – By Therapeutic Models
- 7.2.1 Chemotherapy – Overview/Analysis
- 7.2.2 Targeted Therapy – Overview/Analysis
- 7.2.3 Immunotherapy – Overview/Analysis
- 7.2.4 Hormonal Therapy – Overview/Analysis
- 7.2.5 Others – Overview/Analysis
- 7.3 Chemotherapy
- 7.3.1 Global Onculogy Drug Market for Chemotherapy, Revenue (USD Million) 2016 - 2026
- 7.4 Targeted Therapy
- 7.4.1 Global Onculogy Drug Market for Targeted Therapy, Revenue (USD Million) 2016 - 2026
- 7.5 Immunotherapy
- 7.5.1 Global Onculogy Drug Market for Immunotherapy, Revenue (USD Million) 2016 - 2026
- 7.6 Hormonal Therapy
- 7.6.1 Global Onculogy Drug Market for Hormonal Therapy, Revenue (USD Million) 2016 - 2026
- 7.7 Others
- 7.7.1 Global Onculogy Drug Market for Others, Revenue (USD Million) 2016 - 2026
- 8.1 Global Onculogy Drug Market Overview: By Cancer Type
- 8.1.1 Global Onculogy Drug Market Revenue Share, By Cancer Type, 2019 & 2026
- 8.2 Global Onculogy Drug Market Analysis/Overview – By Cancer Type
- 8.2.1 Breast Cancer – Overview/Analysis
- 8.2.2 Blood Cancer – Overview/Analysis
- 8.2.3 Prostate Cancer – Overview/Analysis
- 8.2.4 Skin Cancer – Overview/Analysis
- 8.2.5 Lung Cancer – Overview/Analysis
- 8.2.6 Others – Overview/Analysis
- 8.3 Breast Cancer
- 8.3.1 Global Onculogy Drug Market for Breast Cancer, Revenue (USD Million) 2016 - 2026
- 8.4 Blood Cancer
- 8.4.1 Global Onculogy Drug Market for Blood Cancer, Revenue (USD Million) 2016 - 2026
- 8.5 Prostate Cancer
- 8.5.1 Global Onculogy Drug Market for Prostate Cancer, Revenue (USD Million) 2016 - 2026
- 8.6 Skin Cancer
- 8.6.1 Global Onculogy Drug Market for Skin Cancer, Revenue (USD Million) 2016 - 2026
- 8.7 Lung Cancer
- 8.7.1 Global Onculogy Drug Market for Lung Cancer, Revenue (USD Million) 2016 - 2026
- 8.8 Others
- 8.8.1 Global Onculogy Drug Market for Others, Revenue (USD Million) 2016 - 2026
- 6.1 Company Market Share Analysis - 2019
- Chapter 9 Onculogy Drug Market – Regional Analysis
- 9.1 Global Onculogy Drug Market: Regional Overview
- 9.1.1 Global Onculogy Drug Market Revenue Share, by Region, 2019 & 2026
- 9.1.2 Global Onculogy Drug Market Revenue, by Region, 2016 – 2026 (USD Million)
- 9.2 North America
- 9.2.1 North America Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
- 9.2.2 North America Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
- 9.2.3 North America Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
- 9.2.4 North America Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
- 9.2.5 U.S.
- 9.2.6 Canada
- 9.3 Europe
- 9.3.1 Europe Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
- 9.3.2 Europe Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
- 9.3.3 Europe Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
- 9.3.4 Europe Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
- 9.3.5 Germany
- 9.3.6 France
- 9.3.7 U.K.
- 9.3.8 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Asia Pacific Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
- 9.4.2 Asia Pacific Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
- 9.4.3 Asia Pacific Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
- 9.4.4 Asia Pacific Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
- 9.4.5 China
- 9.4.6 Japan
- 9.4.7 India
- 9.4.8 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Latin America Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
- 9.5.2 Latin America Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
- 9.5.3 Latin America Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
- 9.5.4 Latin America Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
- 9.5.5 Brazil
- 9.5.6 Rest of Latin America
- 9.6 The Middle-East and Africa
- 9.6.1 The Middle-East and Africa Onculogy Drug Market Revenue, 2016 - 2026 (USD Million)
- 9.6.2 The Middle-East and Africa Onculogy Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
- 9.6.3 The Middle-East and Africa Onculogy Drug Market Revenue, By Therapeutic Models, 2016 – 2026
- 9.6.4 The Middle-East and Africa Onculogy Drug Market Revenue, By Cancer Type, 2016 – 2026
- 9.6.5 GCC Countries
- 9.6.6 Rest of Middle-East Africa
- 9.1 Global Onculogy Drug Market: Regional Overview
- Chapter 10 Company Profiles
- 10.1 Johnson & Johnson
- 10.1.1 Company Overview
- 10.1.2 Financial Overview
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Amgen Inc.
- 10.3 Eli Lilly Co.
- 10.4 GSK
- 10.5 Roche Diagnostics
- 10.6 Merck & Co.
- 10.7 Pfizer
- 10.8 Sanofi
- 10.9 Novartis AG
- 10.10 Celgene Corporation
- 10.1 Johnson & Johnson
Table Of Figures
List of Figures
FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 5 Porter’s Five Forces Analysis for Global Oncology Drug Market
FIG. 6 Global Oncology Drug Market Attractiveness, By Therapeutic Models
FIG. 7 Global Oncology Drug Market Attractiveness, By Cancer Type
FIG. 8 Global Oncology Drug Market Attractiveness, By End-User
FIG. 9 Company Share Analysis, 2019
FIG. 10 Global Oncology Drug Market Revenue Share, By Therapeutic Models, 2019 & 2026
FIG. 11 Global Oncology Drug Market for Chemotherapy, Revenue (USD Million) 2016 - 2026
FIG. 12 Global Oncology Drug Market for Targeted Therapy, Revenue (USD Million) 2016 - 2026
FIG. 13 Global Oncology Drug Market for Immunotherapy, Revenue (USD Million) 2016 - 2026
FIG. 14 Global Oncology Drug Market for Hormonal Therapy, Revenue (USD Million) 2016 - 2026
FIG. 15 Global Oncology Drug Market for Others, Revenue (USD Million) 2016 - 2026
FIG. 16 Global Oncology Drug Market Revenue Share, By Cancer Type, 2019 & 2026
FIG. 17 Global Oncology Drug Market for Breast Cancer, Revenue (USD Million) 2016 - 2026
FIG. 18 Global Oncology Drug Market for Blood Cancer, Revenue (USD Million) 2016 - 2026
FIG. 19 Global Oncology Drug Market for Prostate Cancer, Revenue (USD Million) 2016 - 2026
FIG. 20 Global Oncology Drug Market for Skin Cancer, Revenue (USD Million) 2016 - 2026
FIG. 21 Global Oncology Drug Market for Lung Cancer, Revenue (USD Million) 2016 - 2026
FIG. 22 Global Oncology Drug Market for Others, Revenue (USD Million) 2016 - 2026
FIG. 23 Global Oncology Drug Market Revenue Share, by Region, 2019 & 2026
FIG. 24 North America Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 25 Europe Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 26 Asia Pacific Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 27 Latin America Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 28 The Middle-East and Africa Oncology Drug Market Revenue, 2016 - 2026 (USD Million)
FIG. 29 Johnson & Johnson Business Segment Revenue Share, 2018 (%)
FIG. 30 Johnson & Johnson Geographical Segment Revenue Share, 2018 (%)
Table Of Tables
List of Tables
TABLE 1 Global Oncology Drug Market: Snapshot
TABLE 2 Drivers of the Oncology Drug Market: Impact Analysis
TABLE 3 Restraints for the Oncology Drug Market: Impact Analysis
TABLE 4 Global Oncology Drug Market Revenue, by Region, 2016 – 2026 (USD Million)
TABLE 5 North America Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 6 North America Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 7 North America Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
TABLE 8 Europe Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 9 Europe Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 10 Europe Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
TABLE 11 Asia Pacific Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 12 Asia Pacific Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 13 Asia Pacific Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
TABLE 14 Latin America Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 15 Latin America Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 16 Latin America Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
TABLE 17 The Middle-East and Africa Oncology Drug Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 18 The Middle-East and Africa Oncology Drug Market Revenue, By Therapeutic Models, 2016 – 2026 (USD Million)
TABLE 19 The Middle-East and Africa Oncology Drug Market Revenue, By Cancer Type, 2016 – 2026 (USD Million)
Methodology
FrequentlyAsked Questions
An oncology drug is a medication used to treat cancer. It targets cancer cells to slow or stop disease progression.
The global oncology drug market is expected to be driven by the increasing cancer incidence, targeted therapy adoption, and advancements in oncology drug development.
According to study, the global oncology drug market size was worth around USD 146.9 Billion in 2023 and is predicted to grow to around USD 473.1 Billion By 2032.
The global oncology drug market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 14.0% during the forecast period from 2024-2032.
The global oncology drug industry is projected to be challenged by Key challenges include long R&D timelines, high clinical trial costs, and complex regulatory approvals. Pricing pressure and reimbursement uncertainty impact commercialization.
The Opportunities include targeted therapies, immuno-oncology combinations, and biomarker-driven treatment. Accelerated approvals and expanded indications fuel pipeline growth will offer significant growth opportunities in the oncology drug market.
Targeted therapies and immuno-oncology drugs; personalized cancer treatment approaches; accelerated regulatory pathways are the emerging trends and innovations impacting the oncology drug market.
The global oncology drug market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global oncology drug market are; Johnson & Johnson, Amgen Inc., Eli lilly & Co., GlaxoSmithKline, Roche diagnostics, Merck & Co., Pfizer, Sanofi, Celgene Corporation, and Novartis AG. and others.
The report explores crucial aspects of the oncology drug market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
